DR info

Clinical trials : 21 / Drugs : 40 - (DrugBank : 11) / Drug target genes : 10 - Drug target pathways : 50

Marfan syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
167	Marfan syndrome
96	Crohn disease
86	Pulmonary arterial hypertension
6	Parkinson disease
67	Polycystic kidney disease
58	Hypertrophic cardiomyopathy
70	Spinal stenosis
226	Interstitial cystitis with Hunners ulcer
97	Ulcerative colitis
13	Multiple sclerosis/Neuromyelitis optica
193	Prader-Willi syndrome
17	Multiple system atrophy
57	Idiopathic dilated cardiomyopathy
46	Malignant rheumatoid arthritis
81	Congenital adrenal hyperplasia
278	Huge lymphatic malformation with cervicofacial lesion
215	Tetralogy of Fallot
272	Fibrodysplasia ossificans progressiva
140	Dorabe syndrome
50	Dermatomyositis
144	Lennox-Gastaut syndrome
90	Retinitis pigmentosa
298	Hereditary pancreatitis
113	Muscular dystrophy
156	Rett syndrome
51	Scleroderma
169	Menkes disease
170	Occipital horn syndrome
227	Osler disease
22	Moyamoya disease
210	Single Ventricle
66	IgA nephropathy
158	Tuberous sclerosis
296	Biliary atresia
11	Myasthenia gravis
157	Sturge-Weber syndrome
222	Primary nephrotic syndrome
111	Congenital myopathy